You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 2
  • 462 A randomised open-label phase I/II study adding ONCOS-102 to pemetrexed/cisplatin in patients with unresectable malignant pleural mesothelioma – 24 month survival data

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
462 A randomised open-label phase I/II study adding ONCOS-102 to pemetrexed/cisplatin in patients with unresectable malignant pleural mesothelioma – 24 month survival data
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to September 2024

AbstractFullPdf
Nov 2021318014
Dec 20216206
Jan 20225604
Feb 20223805
Mar 202216607
Apr 20227405
May 20222607
Jun 20222608
Jul 2022801
Aug 20221803
Sep 20222009
Oct 20221805
Nov 20221006
Dec 20221203
Jan 20231402
Feb 20232204
Mar 20231802
Apr 20231603
May 20232403
Jun 2023803
Jul 20231206
Aug 20231202
Sep 20231601
Oct 20231803
Nov 20231204
Dec 20234002
Jan 20241401
Feb 20242003
Mar 20241605
Apr 20241002
May 20242204
Jun 20242004
Jul 2024803
Aug 20241607
Sep 202412018
Total12020165